ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development
Open accessThe DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Abstract
SUMMARY Biomarkers for predicting prognosis are critical to treating colorectal cancer (CRC) patients. We found that CSN6, a subunit of COP9 signalosome, is overexpressed in CRC samples and that CSN6 overexpression is correlated with poor patient survival. Mechanistic studies revealed that CSN6 is deregulated by EGFR signaling, in which ERK2 binds directly to CSN6 Leu163/Val165 and phosphorylates CSN6 at Ser148. Furthermore, CSN6 regulated β-Trcp and stabilizes β-catenin expression by blocking the ubiquitin-proteasome pathway, thereby promoting CRC development. High CSN6 expression was positively correlated with ERK2 activation and β-catenin overexpression in CRC samples, and inhibiting CSN6 stability with cetuximab reduced colon cancer growth. Taken together, our study’s findings indicate that the deregulation of β-catenin by ERK2-activated CSN6 is important for CRC development.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
K-ras Mutations and Benefit from Cetuximab in Advanced Colorectal Cancer
Karapetis, C. S., Khambata-Ford, S., Jonker, D. J., O'Callaghan, C. J., Tu, D., Tebbutt, N. C., Simes, R. J., Chalchal, H., Shapiro, J. D., Robitaille, S., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804385 · Cited by 3,622
Wild-Type KRAS Is Required for Panitumumab Efficacy in Patients With Metastatic Colorectal Cancer
Amado, R. G., Wolf, M., Peeters, M., Van Cutsem, E., Siena, S., Freeman, D. J., Juan, T., Sikorski, R., Suggs, S., Radinsky, R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.7116 · Cited by 3,207 · cited 1×
“For example, RAS and BRAF mutations have impact on the clinical management of CRC (Amado et al., 2008; Bardelli and Siena, 2010; Douillard et al., 2013; Pietrantonio et al., 2015).”
Panitumumab–FOLFOX4 Treatment and RAS Mutations in Colorectal Cancer
Douillard, J.-Y., Oliner, K. S., Siena, S., Tabernero, J., Burkes, R., Barugel, M., Humblet, Y., Bodoky, G., Cunningham, D., Jassem, J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1305275 · Cited by 2,263 · cited 3×
“For example, RAS and BRAF mutations have impact on the clinical management of CRC (Amado et al., 2008; Bardelli and Siena, 2010; Douillard et al., 2013; Pietrantonio et al., 2015).”
Allegra, C. J., Jessup, J. M., Somerfield, M. R., Hamilton, S. R., Hammond, E. H., Hayes, D. F., McAllister, P. K., Morton, R. F., & Schilsky, R. L. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.21.9170 · Cited by 1,156 · cited 1×
“The EGF-ERK-CSN6-b-Catenin Axis Promotes Cell Proliferation and Tumor Growth The EGF/ERK pathway is often deregulated in CRC, and the monoclonal antibody cetuximab, an EGFR inhibitor, is used clinically to correct this deregulation (Allegra et al., 2009; Prewett et al., 2002).”
A conserved docking motif in MAP kinases common to substrates, activators and regulators
Tanoue, T., Adachi, M., Moriguchi, T., & Nishida, E. (2000) · Nature Cell Biology · doi:10.1038/35000065 · Cited by 816
Molecular Mechanisms of Resistance to Cetuximab and Panitumumab in Colorectal Cancer
Bardelli, A., & Siena, S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6116 · Cited by 746
Pietrantonio, F., Petrelli, F., Coinu, A., Di Bartolomeo, M., Borgonovo, K., Maggi, C., Cabiddu, M., Iacovelli, R., Bossi, I., Lonati, V., et al. (2015) · European Journal of Cancer · doi:10.1016/j.ejca.2015.01.054 · Cited by 486 · cited 3×
“(2013) show that RAS mutations (any KRAS or NRAS mutations in exon 2, 3, or 4) in CRC could be about 52%, whereas BRAF V660E mutation is found in 20% of colonic tumors (Fariña-Sarasqueta et al., 2010; Pietrantonio et al., 2015).”
Mao, C., Yang, Z. Y., Hu, X. F., Chen, Q., & Tang, J. L. (2012) · Annals of Oncology · doi:10.1093/annonc/mdr464 · Cited by 188
Selectivity of Docking Sites in MAPK Kinases
Bardwell, A. J., Frankson, E., & Bardwell, L. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m900080200 · Cited by 127 · cited 2×
“Also, many MAPK substrates contain dockingmotifs (D-sites), which consist of a cluster of basic residues, a short spacer, and a hydrophobic (4)-X-hydrophobic (4) motif (K/R -X1–6 -4-X -4) (Bardwell, 2006; Bardwell et al., 2009; Whisenant et al., 2010).”
Cited by
Deubiquitination and Stabilization of PD-L1 by CSN5
Lim, S.-O., Li, C.-W., Xia, W., Cha, J.-H., Chan, L.-C., Wu, Y., Chang, S.-S., Lin, W.-C., Hsu, J.-M., Hsu, Y.-H., et al. (2016) · Cancer Cell · doi:10.1016/j.ccell.2016.10.010 · Cited by 793
Self-citationIGF2BP2 promotes the progression of colorectal cancer through a YAP‐dependent mechanism
Cui, J., Tian, J., Wang, W., He, T., Li, X., Gu, C., Wang, L., Wu, J., & Shang, A. (2021) · Cancer Science · doi:10.1111/cas.15083 · Cited by 90
Self-citationImpact of diabetes on promoting the growth of breast cancer
Chou, P., Choi, H. H., Huang, Y., Fuentes‐Mattei, E., Velazquez‐Torres, G., Zhang, F., Phan, L., Lee, J., Shi, Y., Bankson, J. A., et al. (2021) · Cancer Communications · doi:10.1002/cac2.12147 · Cited by 35
“For the Myc ubiquitination assay, BT-474 cells were treated withMG132 for 6 hours before sample collection as previously described [30, 31].”
MethodSelf-citation
Metadata
- Authors
- Fang, L., Lu, W., Choi, H. H., Yeung, S.-C. J., Tung, J.-Y., Hsiao, C.-D., Fuentes-Mattei, E., Menter, D., Chen, C., Wang, L., Wang, J., & Lee, M.-H.
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2015-08
- Volume
- 28
- Issue
- 2
- Pages
- 183-197
- ISSN
- 1535-6108 (ISSN-L)
- OpenAlex
- W1959684413
- Cited by
- 80
- References
- 9
- FWCI
- 2.32
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development. https://app.cochat.ai/papers/10.1016/j.ccell.2015.07.004
- The paper
- Fang, L., Lu, W., Choi, H. H., Yeung, S.-C. J., Tung, J.-Y., Hsiao, C.-D., Fuentes-Mattei, E., Menter, D., Chen, C., Wang, L., Wang, J., & Lee, M.-H. (2015). ERK2-Dependent Phosphorylation of CSN6 Is Critical in Colorectal Cancer Development. Cancer Cell. https://doi.org/10.1016/j.ccell.2015.07.004
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.